📰 Sun Pharma News
Page 48 - Sun Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sun Pharma. Real-time updates on events, politics, business and more.
February 1, 2024
While it's not a full-fledged budget like the one presented in July, it can still impact the stock market in several ways.
February 1, 2024
Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 340669.58 Crore) operating in Pharmaceuticals sector.
February 1, 2024
The stock was trading with minor gains at the opening time and hit the days high of Rs 1,430.45 on the NSE, up 0.84% over the Wednesday closing price.
February 1, 2024
Shares of MSIL closed at Rs 10,183.30 apiece on BSE, up 2.27 per cent from previous close
February 1, 2024
Benchmark equity indices began the trade on an optimistic note on Thursday but later faced heavy volatile trends ahead of presentation of interim Budget
February 1, 2024
Larsen & Toubro, Titan, Bajaj Finserv and JSW Steel were the major laggards. Goods and Services Tax collections jumped 10.4 per cent to over Rs 1.72 lakh crore in January, reflecting buoyant economic activity and setting the stage for the next phase of GST reforms
February 1, 2024
New Delhi, Feb 1: Union Finance Minister Nirmala Sitharaman on Thursday began her Interim Budget speech. This will be her sixth Budget as the Finance Minister and last in the second term of the Modi government. The interim budget will take care of the financial needs of the intervening period until a government is formed
February 1, 2024
The interim budget exemplifies the governments dedication to Viksit Bharat. It focuses on fortifying the economy, boosting infrastructure, and promoting green growth through bio-manufacturing. The budget also expands universal health coverage and introduces the cervical cancer vaccination program.
January 31, 2024
Adani Wilmar shares were up 0.24 per cent at Rs 358.50, as the Adani group firm was expected to report a muted set of quarterly earnings, with revenue falling in double-digits and Ebitda tumbling over 50 per cent.
January 31, 2024
(This story has not been edited by THE WEEK and is auto-generated from a PTI